Todd C. Davis - Feb 21, 2024 Form 4 Insider Report for Chromocell Therapeutics Corp (CHRO)

Role
Director
Signature
/s/ Todd Davis
Stock symbol
CHRO
Transactions as of
Feb 21, 2024
Transactions value $
-$34,998
Form type
4
Date filed
2/23/2024, 05:15 PM
Previous filing
Feb 15, 2024
Next filing
Feb 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRO Common Stock Options Exercise $140K +29.2K $4.80* 29.2K Feb 21, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRO Secured Convertible Promissory Note Conversion of derivative security -$175K 0 Feb 21, 2024 Common Stock 29.2K $4.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the face amount of $175,000 this senior secured convertible promissory note, due February 29, 2024, which automatically converted into 29,167 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering, which is $6.00 per share.